Absence of antibody to HTLV I and III in Sera of Canadian patients with multiple sclerosis and chronic myelopathy
β Scribed by Dr G. P. A. Rice; H. A. Armstrong; D. E. Bulman; D. W. Paty; G. C. Ebers
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 244 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
β¦ Synopsis
Recently, elevated titers of antibody to HTLV I have been demonstrated in patients with tropical spastic paraparesis and multiple sclerosis. We evaluated the possible role of human retroviruses HTLV I and III in Canadian patients with multiple sclerosis and chronic idiopathic myelopathy. Using sensitive enzyme immunoassays, we were unable to find antibody to either HTLV I or III in 201 patients with multiple sclerosis, 29 patients with chronic myelopathy, 51 patients with other neurological disorders, or 29 normal subjects. These data do not support a role for these viruses in the cause of sporadic multiple sclerosis and chronic myelopathy in a regionally based Canadian population, but do not exclude a role for other antigenically distinct retroviruses.
π SIMILAR VOLUMES
## Abstract ## Objective To determine if antibodies to cyclic citrullinated peptide (antiβCCP) are found in chronic hepatitis C virus (HCV) infection. ## Methods Rheumatoid factor (RF) and antiβCCP were measured in sera from 50 patients with HCV infection but without cryoglobulinemia, sera from